Abstract
Toxicity evaluation of inorganic nanoparticles in cell lines and in whole animals has been extensively explored in recent years. However, conflicting results have been reported regarding size-dependent toxicity and biokinetics in vitro and in vivo, and thus, basic questions regarding whether nanoparticles, ranged from 1 to 100 nm in size, are comparatively more toxic than larger-sized particles remain unanswered. This may be closely associated with changes in physicochemical properties of nanoparticles in biological fluids. Understanding in vivo physiological barriers, biological fates, and absorption mechanism of nanoparticles upon exposure routes will be useful to predict their toxicity potential. This review will highlight the critical points to be considered in order to evaluate the toxicity of inorganic nanoparticles, and discuss the issues and challenges emerging in the field of nanotoxicology.
Similar content being viewed by others
References
Choi, S. J. & Choy, J. H. Layered double hydroxide nanoparticles as target-specific delivery carriers: uptake mechanism and toxicity. Nanomedicine (Lond) 6: 803–814 (2011).
Xia, T., Li, N. & Nel, A. E. Potential health impact of nanoparticles. Annu Rev Public Health 30:137–150 (2009).
Choi, S. J., Oh, J. M. & Choy, J. H. Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells. J Inorg Biochem 103:463–471 (2009).
Fernandez, D., Garcia-Gomez, C. & Babin, M. In vitro evaluation of cellular responses induced by ZnO nanoparticles, zinc ions and bulk ZnO in fish cells. Sci Total Environ 452–453:262–274 (2013).
Cho, W. S. et al. Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration. Part Fibre Toxicol 10:9 (2013).
Wang, J. et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett 168:176–185 (2007).
Khlebtsov, N. & Dykman, L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev 40:1647–1671 (2011).
Almeida, J. P., Chen, A. L., Foster, A. & Drezek, R. In vivo biodistribution of nanoparticles. Nanomedicine (Lond) 6:815–835 (2011).
Podila, R. & Brown, J. M. Toxicity of engineered nanomaterials: a physicochemical perspective. J Biochem Mol Toxicol 27:50–55 (2013).
Lai, D. Y. Toward toxicity testing of nanomaterials in the 21st century: a paradigm for moving forward. WIRES Nanomed Nanobi 4:1–15 (2012).
Klien, K. & Godnic-Cvar, J. Genotoxicity of metal nanoparticles: focus on in vivo studies. Arh Hig Rada Toksikol 63:133–145 (2012).
Teeguarden, J. G. et al. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. Toxicol Sci 95:300–312 (2007).
Campagnolo, L. et al. Physico-chemical properties mediating reproductive and developmental toxicity of engineered nanomaterials. Curr Med Chem 19:4488–4494 (2012).
Oberdorster, G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 267:89–105 (2010).
Lundqvist, M. et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. P Natl Acad Sci USA 105:14265–14270 (2008).
Sasidharan, N. P., Chandran, P. & Sudheer Khan, S. Interaction of colloidal zinc oxide nanoparticles with bovine serum albumin and its adsorption isotherms and kinetics. Colloid Surface B 102:195–201 (2013).
Lousinian, S., Missopolinou, D. & Panayiotou, C. Fibrinogen adsorption on zinc oxide nanoparticles: a Micro-Differential Scanning Calorimetry analysis. J Colloid Interf Sci 395:294–299 (2013).
Deng, Z. J. et al. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 20: 455101–455109 (2009).
Sharma, V. K. Aggregation and toxicity of titanium dioxide nanoparticles in aquatic environment-a review. J Environ Sci Health A Tox Hazard Subst Environ Eng 44:1485–1495 (2009).
Albanese, A., Tang, P. S. & Chan, W. C. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Ann Rev Biomed Eng 14:1–16 (2012).
Kendall, M. & Holgate, S. Health impact and toxicological effects of nanomaterials in the lung. Respirology 17:743–758 (2012).
Waalewijn-Kool, P. L., Ortiz, M. D., Lofts, S. & van Gestel, C. A. The effect of pH on the toxicity of ZnO nanoparticles to Folsomia candida in amended field soil. Environ Toxicol Chem DOI: 10.1002/etc.2302 (2013).
Misra, S. K. et al. The complexity of nanoparticle dissolution and its importance in nanotoxicological studies. Sci Total Environ 438:225–232 (2012).
Li, M., Lin, D. & Zhu, L. Effects of water chemistry on the dissolution of ZnO nanoparticles and their toxicity to Escherichia coli. Environ Pollut 173:97–102 (2013).
Mudunkotuwa, I. A., Rupasinghe, T., Wu, C. M. & Grassian, V. H. Dissolution of ZnO nanoparticles at circumneutral pH: a study of size effects in the presence and absence of citric acid. Langmuir 28:396–403 (2012).
Dobias, J. & Bernier-Latmani, R. Silver Release from Silver Nanoparticles in Natural Waters. Environ Sci Technol 47:4140–4146 (2013).
Loeschner, K. et al. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8:18 (2011).
Gilbert, B. et al. The fate of ZnO nanoparticles administered to human bronchial epithelial cells. ACS nano 6:4921–4930 (2012).
Larner, F. et al. Tracing bioavailability of ZnO nanoparticles using stable isotope labeling. Environ Sci Technol 46:12137–12145 (2012).
Baek, M. et al. Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int J Nanomed 7:3081–3097 (2012).
Diedrich, T. et al. The dissolution rates of SiO2 nanoparticles as a function of particle size. Environ Sci Technol 46:4909–4915 (2012).
Shahbazi, M. A. & Santos, H. A. Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication. Curr Drug Metab 14:28–56 (2013).
des Rieux, A. et al. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 116:1–27 (2006).
Park, K. et al. Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch Pharm Res 34:153–158 (2011).
Owens, D. E., 3rd & Peppas, N. A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307:93–102 (2006).
Longmire, M., Choyke, P. L. & Kobayashi, H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 3:703–717 (2008).
Choi, H. S. et al. Renal clearance of quantum dots. Nat Biotechnol 25:1165–1170 (2007).
Donaldson, K. & Poland, C. A. Inhaled nanoparticles and lung cancer — what we can learn from conventional particle toxicology. Swiss Med Wkly 142:w13547 (2012).
Klein, C. L. et al. Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies. Arch Toxicol 86:1137–1151 (2012).
Castranova, V. Overview of current toxicological knowledge of engineered nanoparticles. J Occup Environ Med 53:S14–17 (2011).
Crosera, M. et al. Nanoparticle dermal absorption and toxicity: a review of the literature. Int Arch Occ Env Hea 82:1043–1055 (2009).
Gulson, B. et al. Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol Sci 118:140–149 (2010).
Hirai, T. et al. Dermal absorption of amorphous nanosilica particles after topical exposure for three days. Pharmazie 67:742–743 (2012).
Ohlson, M., Sorensson, J. & Haraldsson, B. A gelmembrane model of glomerular charge and size selectivity in series. Am J Physiol-Renal 280:F396–405 (2001).
Xu, Z. P., Zeng, Q. H., Lu, G. Q. & Yu, A. B. Inorganic nanoparticles as carriers for efficient cellular delivery. Chem Eng Sci 61:1027–1040 (2006).
Oh, J. M., Choi, S. J., Kim, S. T. & Choy, J. H. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: enhanced efficacy due to clathrinmediated endocytosis. Bioconjug Chem 17:1411–1417 (2006).
Doherty, G. J. & McMahon, H. T. Mechanisms of endocytosis. Annu Rev Biochem 78:857–902 (2009).
He, C., Yin, L., Tang, C. & Yin, C. Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs. Biomaterials 33:8569–8578 (2012).
van der Lubben, I. M., Verhoef, J. C., Borchard, G. & Junginger, H. E. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci 14:201–207 (2001).
Prego, C., Torres, D. & Alonso, M. J. The potential of chitosan for the oral administration of peptides. Expert Opin Drug Del 2:843–854 (2005).
Ishizawa, T., Hayashi, M. & Awazu, S. Paracellular and transcellular permeabilities of fosfomycin across small intestinal membrane of rat and rabbit by voltageclamp method. J Pharmacobiody 14:583–589 (1991).
Li, C. H. et al. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology 6:746–756 (2012).
Jenkins, J. T. et al. Excretion and toxicity of gold-iron nanoparticles. Nanomedicine 9:356–365 (2013).
Paek, H. J. et al. Modulation of the pharmacokinetics of zinc oxide nanoparticles and their fates in vivo. Nanoscale DOI: 10.1039/C3NR02140H (2013).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Choi, SJ., Lee, J.K., Jeong, J. et al. Toxicity evaluation of inorganic nanoparticles: considerations and challenges. Mol. Cell. Toxicol. 9, 205–210 (2013). https://doi.org/10.1007/s13273-013-0026-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13273-013-0026-z